000 01408 a2200421 4500
005 20250511215612.0
264 0 _c19910419
008 199104s 0 0 eng d
022 _a0270-4137
024 7 _a10.1002/pros.2990180203
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJuniewicz, P E
245 0 0 _aEvaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer.
_h[electronic resource]
260 _bThe Prostate
_c1991
300 _a105-15 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAndrogen Antagonists
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aDrug Administration Schedule
650 0 4 _aFlutamide
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aOrchiectomy
650 0 4 _aPregnanes
_xadministration & dosage
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aPyrazoles
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
700 1 _aFetrow, N
700 1 _aMarinelli, J
700 1 _aWolf, M
700 1 _aYoung, E
700 1 _aLamb, J
700 1 _aIsaacs, J T
773 0 _tThe Prostate
_gvol. 18
_gno. 2
_gp. 105-15
856 4 0 _uhttps://doi.org/10.1002/pros.2990180203
_zAvailable from publisher's website
999 _c2012290
_d2012290